NCT04281810

Brief Summary

Muscle atrophy and diaphragm dysfunction are common with prolonged mechanical ventilation (PMV). Electrical stimulation has been shown to be beneficial in severe chronic heart failure and chronic obstructive pulmonary disease. However, its effect on PMV is unclear. This study examined the effects of transcutaneous electrical diaphragmatic stimulation (TEDS) on respiratory muscle strength and weaning outcomes in patients with PMV.

Trial Health

87
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
59

participants targeted

Target at P25-P50 for not_applicable

Timeline
Completed

Started Apr 2017

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
completed

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

April 20, 2017

Completed
1.4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

September 29, 2018

Completed
10 months until next milestone

Study Completion

Last participant's last visit for all outcomes

July 25, 2019

Completed
7 months until next milestone

First Submitted

Initial submission to the registry

February 18, 2020

Completed
6 days until next milestone

First Posted

Study publicly available on registry

February 24, 2020

Completed
Last Updated

February 24, 2020

Status Verified

February 1, 2020

Enrollment Period

1.4 years

First QC Date

February 18, 2020

Last Update Submit

February 21, 2020

Conditions

Keywords

electrical stimulationdiaphragmaticweaningrespiratory muscle

Outcome Measures

Primary Outcomes (8)

  • tidal volume

    The tidal volume was measured by a spirometer

    1st day of intervention

  • tidal volume

    The tidal volume was measured by a spirometer

    through study completion,an average of 4 weeks

  • rapid shallow breathing index

    respiratory rate/tidal volume

    1st day of intervention

  • rapid shallow breathing index

    respiratory rate/tidal volume

    through study completion,an average of 4 weeks

  • respiratory muscle strength (maximal inspiratory pressure)

    pressure gauge

    the 1st day of intervention

  • respiratory muscle strength (maximal expiratory pressure)

    pressure gauge

    the 1st day of intervention

  • respiratory muscle strength (maximal inspiratory pressure)

    pressure gauge

    through study completion,an average of 4 weeks

  • respiratory muscle strength (maximal expiratory pressure)

    pressure gauge

    through study completion,an average of 4 weeks

Secondary Outcomes (2)

  • weaning rate

    through study completion,an average of 7 weeks

  • length of stay in respiratory care center

    through study completion,an average of 7 weeks

Study Arms (2)

TEDS

EXPERIMENTAL

Subjects received transcutaneous electrical diaphragm stimulation (TEDS) for 30min/ day till the end of the weaning trial

Device: transcutaneous electric diaphragm stimulation

Control

NO INTERVENTION

Subjects received similar medical treatment except for the TEDS program.

Interventions

The electrodes were placed on the parasternal region beside the xiphoid process; and the sixth and seventh intercostal spaces in line with the mid-axillary line. TEDS was set as biphasic waves, frequency of 30 Hz, pulse width of 400 μs, and rise time of 0.7s.

TEDS

Eligibility Criteria

Age20 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Age ≥ 20 years;
  • MV for \> 6 h/day for \> 21 days;
  • Medical stability (PaO2 ≥ 60 mmHg at 40% FiO2, absence of signs and symptoms of infection, and hemodynamic stability).

You may not qualify if:

  • Acute lung or systemic infection, hemodynamic instability, patients with pacemakers, abdominal distention, and pregnancy.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Chang Gung University

Taoyuan, Tao-Yuan, 333, Taiwan

Location

Study Officials

  • Yi-Fei Hsin

    Chang Gung Memorial Hospital

    PRINCIPAL INVESTIGATOR
  • Yen-Huey Chen

    Chang Gung University

    STUDY DIRECTOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
SINGLE
Who Masked
PARTICIPANT
Masking Details
Subjects were not informed of the results of allocation
Purpose
OTHER
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

February 18, 2020

First Posted

February 24, 2020

Study Start

April 20, 2017

Primary Completion

September 29, 2018

Study Completion

July 25, 2019

Last Updated

February 24, 2020

Record last verified: 2020-02

Data Sharing

IPD Sharing
Will not share

Locations